Bausch Health Companies Inc. (NYSE:BHC) Shares Acquired by Franklin Resources Inc.

Franklin Resources Inc. boosted its position in Bausch Health Companies Inc. (NYSE:BHC) by 1.1% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 5,316,822 shares of the company’s stock after acquiring an additional 56,446 shares during the quarter. Franklin Resources Inc.’s holdings in Bausch Health Companies were worth $42,855,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Arrowstreet Capital Limited Partnership lifted its stake in shares of Bausch Health Companies by 46.3% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 4,770,793 shares of the company’s stock worth $38,501,000 after acquiring an additional 1,510,445 shares in the last quarter. SG Americas Securities LLC raised its position in shares of Bausch Health Companies by 62.0% in the 4th quarter. SG Americas Securities LLC now owns 3,301,981 shares of the company’s stock valued at $26,614,000 after purchasing an additional 1,263,706 shares in the last quarter. O Shaughnessy Asset Management LLC boosted its stake in shares of Bausch Health Companies by 989.1% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 611,890 shares of the company’s stock valued at $4,940,000 after buying an additional 555,709 shares during the last quarter. Vanguard Group Inc. grew its position in shares of Bausch Health Companies by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 11,684,859 shares of the company’s stock worth $94,460,000 after buying an additional 145,078 shares in the last quarter. Finally, Range Financial Group LLC bought a new stake in shares of Bausch Health Companies in the fourth quarter worth $1,004,000. 78.65% of the stock is owned by hedge funds and other institutional investors.

Bausch Health Companies Stock Performance

Bausch Health Companies stock opened at $5.34 on Friday. Bausch Health Companies Inc. has a 1 year low of $3.96 and a 1 year high of $10.48. The firm’s 50-day moving average is $6.91 and its 200-day moving average is $7.69. The company has a market cap of $1.96 billion, a P/E ratio of -44.45, a PEG ratio of 0.37 and a beta of 0.43.

Bausch Health Companies (NYSE:BHC) last issued its earnings results on Wednesday, February 19th. The company reported $1.21 EPS for the quarter, missing analysts’ consensus estimates of $1.65 by ($0.44). The company had revenue of $2.56 billion during the quarter, compared to analyst estimates of $2.51 billion. Bausch Health Companies had a negative net margin of 0.48% and a negative return on equity of 577.82%. As a group, sell-side analysts predict that Bausch Health Companies Inc. will post 4.41 earnings per share for the current year.

Analyst Ratings Changes

BHC has been the subject of several recent analyst reports. Jefferies Financial Group reissued a “hold” rating and set a $8.00 price objective (down from $12.00) on shares of Bausch Health Companies in a report on Thursday, February 6th. Royal Bank of Canada lowered their price objective on Bausch Health Companies from $11.00 to $10.00 and set a “sector perform” rating for the company in a report on Thursday, January 30th. One analyst has rated the stock with a sell rating, six have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $7.42.

Bausch Health Companies Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.